Status:
COMPLETED
Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.
Lead Sponsor:
Alexandria University
Collaborating Sponsors:
Damanhour University
Conditions:
Hypertension, Renal
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Hypertension is highly prevalent in hemodialysis (HD) patients and leads to increased morbidity and mortality due to cardiovascular disease(CVD). Left ventricular hypertrophy (LVH) is both a manifesta...
Eligibility Criteria
Inclusion
- On maintenance hemodialysis 3 times weekly for at least 3 months.
- Hypertensive as determined by predialytic BP \> 140/ 90, post-dialytic \> 130/80, home-measured BP \>140/90, Office based BP \>140/90 and/or on antihypertensive medication.
Exclusion
- History of malignancy.
- History of significant valvular heart disease.
- Chronic congestive heart failure.
- History of coronary artery disease.
- Ongoing atrial fibrillation.
- Known drug abuse.
- Known contraindication to Bisoprolol or Amlodipine.
- History of MI
- History of Stroke
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04085562
Start Date
September 1 2019
End Date
February 1 2021
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
El Mowassat University hospital
Alexandria, Egypt